KR20240159636A - 수성 조성물 - Google Patents

수성 조성물 Download PDF

Info

Publication number
KR20240159636A
KR20240159636A KR1020247035255A KR20247035255A KR20240159636A KR 20240159636 A KR20240159636 A KR 20240159636A KR 1020247035255 A KR1020247035255 A KR 1020247035255A KR 20247035255 A KR20247035255 A KR 20247035255A KR 20240159636 A KR20240159636 A KR 20240159636A
Authority
KR
South Korea
Prior art keywords
aqueous composition
sodium
salts
component
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020247035255A
Other languages
English (en)
Korean (ko)
Inventor
리카 오리타니
지세 기타니
아키노리 니시모토
Original Assignee
가부시키가이샤 쓰보타 라보
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 가부시키가이샤 쓰보타 라보 filed Critical 가부시키가이샤 쓰보타 라보
Publication of KR20240159636A publication Critical patent/KR20240159636A/ko
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/1468Containers characterised by specific material properties
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • A61K9/0051Ocular inserts or implants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
KR1020247035255A 2022-03-25 2023-03-24 수성 조성물 Pending KR20240159636A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2022050275 2022-03-25
JPJP-P-2022-050275 2022-03-25
PCT/JP2023/011739 WO2023182480A1 (ja) 2022-03-25 2023-03-24 水性組成物

Publications (1)

Publication Number Publication Date
KR20240159636A true KR20240159636A (ko) 2024-11-05

Family

ID=88101709

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020247035255A Pending KR20240159636A (ko) 2022-03-25 2023-03-24 수성 조성물

Country Status (14)

Country Link
US (1) US20250213510A1 (https=)
EP (1) EP4483867A1 (https=)
JP (1) JPWO2023182480A1 (https=)
KR (1) KR20240159636A (https=)
CN (1) CN118973561A (https=)
AU (1) AU2023240729A1 (https=)
CA (1) CA3254664A1 (https=)
CL (1) CL2024002831A1 (https=)
IL (1) IL315871A (https=)
MA (1) MA67594B1 (https=)
MX (1) MX2024011634A (https=)
PE (1) PE20250746A1 (https=)
TW (1) TW202400133A (https=)
WO (1) WO2023182480A1 (https=)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018164113A1 (ja) 2017-03-06 2018-09-13 学校法人 慶應義塾 マウス近視誘導モデル及び近視予防・抑制のための小胞体ストレス抑制剤
WO2020129965A1 (ja) 2018-12-18 2020-06-25 参天製薬株式会社 4-フェニル酪酸を含有する老視の治療または予防剤

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4806956B2 (ja) * 2004-04-20 2011-11-02 大正製薬株式会社 点眼用液剤
US20070004805A1 (en) * 2005-07-01 2007-01-04 Navinta Llc Process for preparation of liquid dosage form containing sodium 4-phenylbutyrate
JP2009078977A (ja) * 2007-09-25 2009-04-16 Japan Health Science Foundation 心筋の小胞体ストレス抑制剤
EP2127638A1 (en) * 2008-05-30 2009-12-02 Santen Pharmaceutical Co., Ltd Method and composition for treating ocular hypertension and glaucoma
US8962686B2 (en) * 2010-04-28 2015-02-24 The Chinese University Of Hong Kong Method and medication for prevention and treatment of ocular hypertension and glaucoma
WO2018181294A1 (ja) * 2017-03-27 2018-10-04 興和株式会社 医薬製剤

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018164113A1 (ja) 2017-03-06 2018-09-13 学校法人 慶應義塾 マウス近視誘導モデル及び近視予防・抑制のための小胞体ストレス抑制剤
WO2020129965A1 (ja) 2018-12-18 2020-06-25 参天製薬株式会社 4-フェニル酪酸を含有する老視の治療または予防剤

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
부페닐(등록상표)정 500mg 부페닐(등록상표) 과립 94% 첨부 문서

Also Published As

Publication number Publication date
TW202400133A (zh) 2024-01-01
US20250213510A1 (en) 2025-07-03
CN118973561A (zh) 2024-11-15
IL315871A (en) 2024-11-01
CA3254664A1 (en) 2025-07-03
PE20250746A1 (es) 2025-03-13
MA67594A1 (fr) 2025-07-31
CL2024002831A1 (es) 2025-01-24
JPWO2023182480A1 (https=) 2023-09-28
MA67594B1 (fr) 2026-01-30
WO2023182480A1 (ja) 2023-09-28
EP4483867A1 (en) 2025-01-01
AU2023240729A1 (en) 2024-10-03
MX2024011634A (es) 2024-09-30

Similar Documents

Publication Publication Date Title
US20250262149A1 (en) Aqueous ophthalmic solutions of phentolamine and medical uses thereof
US20140308368A1 (en) Ophthalmological aqueous composition
JP7624538B2 (ja) 眼科組成物
JP2014214085A (ja) オロパタジン含有水性組成物
US20230172969A1 (en) Ophthalmic Composition
KR20180052130A (ko) 리포산 콜린 에스테르 조성물, 및 생체적합성 안과용 제형의 생성 방법
JP2022157707A (ja) 眼科組成物
JP2025142313A (ja) ソフトコンタクトレンズ用眼科組成物
JP6148957B2 (ja) プラノプロフェン含有水性組成物
KR20240159636A (ko) 수성 조성물
JPWO2018225729A1 (ja) ソフトコンタクトレンズ用眼科用組成物及びビタミンa分離抑制方法
JP5753958B2 (ja) 澄明な水性液剤
KR20080041621A (ko) 잔탄 검 및 테르페노이드를 포함하는 점안제
HK40113837A (zh) 水性组合物
AU2024347518A1 (en) Aqueous composition
JP5019923B2 (ja) プラノプロフェン含有医薬組成物
WO2024203727A1 (ja) 水性組成物
JP2019142855A (ja) 点眼剤
US20140296348A1 (en) Ophthalmological aqueous composition
EP4534081A1 (en) Ophthalmic composition
EP4534082A1 (en) Ophthalmic composition
JP2025016743A (ja) オロパタジン含有水性組成物
WO2024135344A1 (ja) 眼科用製品
JP2012224629A (ja) ペミロラストを含有する安定な水性組成物
WO2021107033A1 (ja) 医薬組成物

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20241023

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application